Streetbeat News

CVSI

CV Sciences Inc.

https://cvsciences.com/

Employees

71

Industry

All Other Miscellaneous Chemical Product and Preparation Manufacturing

Open

0.03

Mkt cap

6.4M

Volume

96K

High

0.04

P/E Ratio

-1.75

52-wk high

0.10

Low

0.03

Div yield

N/A

52-wk low

0.03

Cannabis stocks experienced significant movements on February 7, 2024, with ESCO Technologies leading the gainers with an unprecedented rise. The sector saw a mix of sharp increases and declines among various companies, indicating a volatile market environment for cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 24, 2024. Notable gainers included Global Hemp Group, Target Group, and Item 9 Labs, with increases of 68.40%, 47.06%, and 14.29% respectively. Trulieve Cannabis and MJ Holdings also saw gains over 11%. Corbus Pharmaceuticals and Neptune Wellness Solutions were among the NASDAQ-listed gainers. Conversely, MedMen Enterprises and EVIO suffered dramatic losses, closing down 99.99% and 98.00%. Other notable losers included Khiron Life Sciences and Cara Therapeutics. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 9:30 pm

On January 23, 2024, several cannabis stocks experienced significant price movements. MedMen Enterprises led the gainers with a 999900.00% increase, closing at $0.01, while Pharmadrug led the losers with a 25.23% decrease, closing at $0.03. Notable gainers included Cann Gr, Khiron Life Sciences, and Canopy Growth, with increases of 125.92%, 59.09%, and 5.22% respectively. Among the losers, Greenlane Holdings and OrganiGram Holdings saw declines of 5.20% and 3.96%. The article was generated by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

The cannabis sector experienced bearish sentiment on January 18, 2024, with a mix of gainers and losers. Notable gainers included Genetic Technologies (GENE) and Urban-gro (UGRO), while significant losers were Aurora Cannabis (ACB), GrowGeneration (GRWG), OrganiGram Holdings (OGI), Tilray Brands (TLRY), Neptune Wellness Solutions (NEPT), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP), and Village Farms International (VFF).

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:30 pm

On January 17, 2024, several cannabis stocks experienced significant price movements. AusCann Group Holdings led the gainers with a 187.50% increase, while MedMen Enterprises and GreenGro Technologies were the biggest losers, both dropping by over 99%. Other notable gainers include Khiron Life Sciences and Maple Leaf Green World, with increases of 54.29% and 32.45%, respectively. Among the losers, 22nd Century Group and OrganiGram Holdings saw declines of 14.72% and 7.89%. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 9:30 pm

The cannabis sector experienced significant movement on January 3, 2024, with a majority of stocks closing higher. Notable gainers included Affinor Growers, Khiron Life Sciences, and CLS Holdings USA, with increases of 74.05%, 66.67%, and 19.40% respectively. Eastside Distilling, Neptune Wellness Solutions, Cara Therapeutics, Genetic Technologies, Village Farms International, Green Thumb Industries, Mexco Energy, and Tilray Brands also saw gains. However, there were some losers, with 1933 Industries, Maple Leaf Green World, Global Compliance, Zoned Properties, and Psychemedics experiencing declines. Scotts Miracle Gro, Corbus Pharmaceuticals, Innovative Industrial Properties, MedMen Enterprises, ESCO Technologies, Item 9 Labs, and EnWave closed lower as well.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 9:30 pm

The article reports on significant price movements in marijuana stocks on January 1, 2024. Notable gainers include Cann Gr, Item 9 Labs, cbdMD, and others with increases ranging from 4.62% to 68.33%. Conversely, several companies experienced declines, with GrowLife leading the losers, dropping 66.67%. Other notable losers include Khiron Life Sciences, MJ Holdings, and OrganiGram Holdings, with decreases ranging from 3.10% to 25.00%. The article was produced by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 01, 2024 | 9:30 pm

On December 29, 2023, several cannabis stocks experienced significant movements. Notable gainers included Cann Gr, Item 9 Labs, and Maple Leaf Green World, with increases of 68.33%, 35.71%, and 24.21% respectively. Conversely, GrowLife, Khiron Life Sciences, and MJ Holdings were among the biggest losers, with declines of 66.67%, 25.00%, and 19.37%. OrganiGram Holdings, Village Farms Intl, and Tilray Brands, all NASDAQ-listed, also saw their shares drop by 7.80%, 4.76%, and 3.73%.

Portfolio Pulse from Benzinga Insights

December 29, 2023 | 9:30 pm

On December 28, 2023, several cannabis stocks experienced significant price movements. Notable gainers included GrowLife, Rhinomed, AusCann Group Holdings, Khiron Life Sciences, and Cara Therapeutics, with GrowLife leading the surge with a 200% increase. On the losing end, The Flowr Corporation saw a dramatic 99.99% decline. Other decliners included CordovaCann, Rocky Mountain High, and Item 9 Labs. The cannabis sector showed high volatility with these sharp price changes.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.